Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism Nav1.7 modulators(Sodium channel protein type IX alpha subunit modulators), Nav1.9 modulators(sodium voltage-gated channel alpha subunit 11 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Oblique Therapeutics ABStartup |
Active Organization Oblique Therapeutics ABStartup |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Erythromelalgia | Discovery | SE | Oblique Therapeutics ABStartup | - |
Pain | Discovery | SE | Oblique Therapeutics ABStartup | - |